Optimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
Jürgen Floege, MD
The Critical Interplay: CKD, HF, and Hyperkalemia
James Burton, DM, FRCP
Javed Butler, MD
Ellie Kelepouris, MD, FACP, FAHA
Patrick Rossignol, MD, PhD
Potassium Binders in Practice: Clinical Trial Evidence
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
Javed Butler, MD, MPH, MBA
Future Directions in Managing Hyperkalemia in CKD and HF
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
Treatment Revolution in IgA Nephropathy
Shikha Wadhwani, MD
Dana Rizk, MD
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
Practical Strategies for Optimizing Outcomes in Patients with Iron Deficiency and Heart Failure
Robert J. Mentz, MD, FHFSA, FACC, FAHA
Piotr Ponikowski, MD, PhD, FESC, FHFA
Implementing the SOC Induction Therapies in AAV
Silke R. Brix, MD, MRCP, SCPR
Bernhard Hellmich, MD
Managing Patients With AAV in the Rheumatology Clinic
Andreas Kronbichler, MD
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Pearls of Wisdom: Optimizing Hyperkalemia Management in Patients with CKD
Matthew R. Weir, MD
Nihar Desai, MD
Elevating Care for Patients With Severe Renal Disease in AAV
Finally, I Can Take a Break from My Itch! Optimizing CKD-aP Treatment
Jörg Latus, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.